The IRIS I (completed) and IRIS III (projected) multicenter protocol studies are intended to be "efficacy trials" to evaluate the nutritional impact (biochemical and functional indicators) of various formats for delivering RDAlevels of single or multiple micronutrients in a "foodlet." Within the discussion that surrounded the presentations at the Lima workshop, issues of "safety evaluation" and assessment of "effectiveness" and "efficiency" arose. This brought in elements of a larger research agenda that had been considered for the straightforward execution of the IRIS I field trial. In the breakout working-group session on research needs, more generic considerations were raised related to the emerging impetus to design and conduct multi-micronutrient intervention investigation. This final paper was not actually part of the invited plenary talks on the program in Lima, but emerged as an attempt to develop and formalize the generic considerations for research-including design, procedures, and ethics-as our group and others go forward around the world.
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a Divine Creator, the rationalism of humankind had evolved to the stage in which it was no longer necessary to believe in a supreme being. The emergence since the 1980s of fundamental fervor among all of the world's religions belies this theory.
In the field of international nutrition research, we have passed through a similar discussion of the demise of a role and utility for investigation. The gauntlet was thrown down in 1993 with the publication of the Martin Forman Memorial Lecture "Sliding toward nutrition malpractice: time to reconsider and redeploy" by Alan Berg [2, 3] . It called for a virtual moratorium on investment in international nutrition research, with diversion of resources into programs instead. A colleague [4] went even further, asserting that the entire discovery needed to solve the nutrition problems was in hand, and that the only legitimate investment for nutrition was in implementation of actions.
The suggestion that investment in international nutrition research is no longer necessary seems to rank with the premature obituary of Mark Twain and the "Death-of-God" theology. Indeed, the litany of important new insights into nutrition biology and new applied nutrition for assessment and intervention just since the debate sparked by the 1993 Forman lecture would fill the pages of an issue of this journal. It is reasonable, therefore, that we strengthen our capacity to select the still-relevant research topics for the area of multi-micronutrient deficiency, and to perform that research with skill and quality.
Hidden hunger comes out of hiding
The years following World War II were filled with the optimism that solving the world's malnutrition problems would be a matter of closing the "protein gap" between the production of dietary protein sources and population explosion in low-income nations [5] . In fact, the production of food crops and livestock has kept pace with population expansion [6] , and most diets deliver adequate protein when energy needs are met. Another aspect of the undernutrition paradigm, however, has begun to occupy public health concernmalnutrition of vitamins and minerals.
It was the research of Sommer et al. [7, 8] in the Aceh Province of Indonesia that extended the importance of vitamin A from nutrition blindness to increased mortality from childhood infections and sparked a surge in interest in micronutrient deficiencies. Developmental deficits resulting from deficiencies of iron [9] and iodine [10] were identified, and the concept of "hidden hunger,"-insidious deficiencies from nutrients present only in minute amounts in the diet-emerged [11] [12] [13] .
The response to hidden hunger was grounded in vertical policies and programs involving each of the afore-mentioned nutrients, but in formats of single-nutrient interventions. For vitamin A, this meant distribution of retinyl palmitate A capsules [14] or fortification of common vehicles with vitamin A [15, 16] . In the case of iodine, salt iodination was the prime focus [17] , but other solo modes of delivery of this nutrient were explored [18, 19] . Iron delivery at the public health level has traditionally been part of a dual-nutrient intervention, combined with folic acid, in prenatal supplements provided to pregnant women.
Multiple-micronutrient supplementation: new research opportunities and requirements
Where the diet is nutrient-rich and the environment benign, one can assume that all of the nutrients needed for growth and nutriture will be consumed, absorbed, and retained. Cultural evolution, however, has forced human populations to subsist on an increasingly narrower variety of food items, dominated usually by one or two staple crops: grains, tubers, or both [20, 21] . The evolutionary transition of humans from huntergatherers to agriculturalists reduced the micronutrient density of the diet. As a consequence, multiple micronutrients are consumed below recommended amounts by all but the most affluent of societies [22] . Combined with parasites, infections, and chronic inflammatory stress, all of which reduce retention of dietary nutrients [23] , humans became vulnerable to having a lower reserve of micronutrients than is necessary for optimal physiologic and biologic function.
There is a growing roster of micronutrients that may be inadequate in segments of human populations and concurrently deficient in many individuals in deprived populations, namely, iron, vitamin A, iodine, fluorine, zinc, folate, vitamin B 12 , and selenium. Iron, vitamin A, and iodine are the triad of micronutrients that galvanized interest during the hidden hunger era. Fluorine, dissolved in water supplies as fluoride, is a protective factor against dental decay, and adjustment of water concentrations or additions of fluoride to salt have been initiated.
Among the newer areas of interest are zinc, folate, vitamin B 12 , and selenium. Some have speculated that low zinc intakes and absorption contribute to linear growth retardation in populations around the world [24] . Recommended dietary allowances (RDA) for folate have doubled since the recognition of its protective role against neural tube defects (NTD) [25] . Rates of NTDs have been found to be high in many low-income nations. Religious proscription, poverty, or both can limit the intake of foods of animal origin, which in turn reduces intake of vitamin B 12 . Widespread Helicobacter pylori infection, moreover, may be contributing to gastric atrophy in residents of S44 developing countries, compromising their ability to absorb vitamin B 12 . Soils in many parts of the world are depleted in selenium. This was a factor in the susceptibility of many Asian populations to Keshan's disease [26] . However, the example of selenium shows us that the problem is even more complex, because we know that selenium deficiency can be partly responsible for the expression of iodine-deficiency manifestations [27, 28] .
Hence, a school of thought in public health nutrition issued a dissent to the dominant approach to deal with micronutrient deficiencies on a nutrient-by-nutrient basis. This was spurred on by the emergence of the concept of intermittent-day supplementation as an intermediate point between campaigns of massive, high-dose supplements and programs requiring daily administration of lower doses [29] . Such experiences began to generate the bases of routines for research design dealing simultaneously with multiple micronutrients. Subsequently, the philosophic and physiologic underpinnings of the rationale for combining multiple micronutrients in both research [30] and intervention programs [31] have been initiated.
Several workshops have been convened over recent years, in Singapore (1998), New York City (1999), Rio de Janeiro (1999), Cape Town (2000), and most recently in Lima, Peru (2001) by a group of professionals from academia, industry and policy agencies. Within the Sub-committee on Nutrition of the Administrative Committee on Coordination of the United Nations' agencies (currently the UN Sub-committee on Nutrition), a commission on micronutrients has been operating for some years, and it has been actively examining the evidence supporting the combination of micronutrients in interventions and their administration on intermittent schedules, such as weekly or biweekly.
Technical and ethical considerations
The research needs for studying micronutrient deficiencies can be interpreted at two levels: (1) the ways to conduct it correctly (tactics), and (2) the selection and priorities of research issues (strategy). The former relates to the quality and rigor of the execution of the research to assure that hypotheses and objectives are correctly addressed. Researchers must be thoroughly familiar with the types of research that apply to the field and the options, opportunities, caveats, and limitations that are inherent. Because special biologic and epidemiologic issues are related to countries with scarce resources for training and equipping facilities, it is essential to recognize potential weaknesses prior to moving to the second level, which is that of the specific priority areas for investigation.
Assessment of the situation
Where are interventions warranted? Where are they contraindicated? To address these questions, a series of diagnostic indicators for at-risk populations are needed. Three strategies can be employed to assess the nutrition situation: (1) social and environmental predictors alone, (2) biomarkers of exposure and status alone, or (3) a combination of both classes of indicators. Although much of the concern for research is related to its development and implementation, it cannot be overlooked that knowing where and when to-and not to-intervene is an important concern. Diagnostic tools that are both acceptable and innocuous but also reliable and cost-effective are needed for many of the nutrients of public health interest. Moreover, indices of nutrient overload are needed to avoid causing harm to some individuals in a population in which other, more deficient segments are being benefited by a micronutrient intervention.
Safety issues
It is no accident that the classic expression for the suitability for use of a medicine is "safe and effective" (in that order). With respect to multinutrient deficiency research, safety should also occupy a position of supremacy. At the scale of the study population to be enrolled in a study, precautions should be made to assure safety. But within the design of research, even if it begins by looking at efficacy as the primary outcome, there must be allowances to detect any negative effects of the intervention.
An implicit aspect of this concern for safety is that adding more micronutrients to an individual's diet, even in those at risk of micronutrient deficiency, may have negative consequences. The following three possibilities must be considered [32] : (1) that health protection can be achieved by inducing or maintaining a lesser nutrient status in a population, (2) that damage to health can result from dosing individuals with additional micronutrients in interventions, and (3) that nutrient imbalance can be produced by highdose supplementation by a single micronutrient.
Being faithful to the mission of "safety first" is often a technical matter, assuring that potential adverse effects are measured, recorded, and analyzed. Growth and morbidity are two such gauges that can pick up untoward effects of micronutrient supplementation. If animal literature or anecdotes provide other insights into possible risks of increasing intakes of a nutrient or a combination of nutrients, the indicators related to these effects must be designed into the research. S45 ment) treatment groups have been questioned in the context of efficacy studies, as one group does not stand to gain any additional benefit if a no-treatment arm is included in the design. Conversely, in a technical sense, one cannot interpret the safety of a dosing scheme with single or multiple micronutrients without including a no-treatment group.
The policy community has a special responsibility to the public to assure that the interventions recommended and implemented will be safe, as well as effective. Risks from micronutrient exposure may be different for the general population compared with certain subgroups, such as those with HIV infection [33] , in whom extra amounts of one or another vitamin or mineral may produce a shorter survival. These hypotheses must be dealt with in research, and their findings addressed in policy. But even the general population is not immune to adverse effects of essential micronutrients, such as when iron is administered to those who are already iron adequate [34, 35] or when β-carotene supplementation produces adverse effects in cigarette smokers [36] . Academic and industrial communities can support this mission by assuring that research is conducted with the highest standards for protection of research subjects and that efforts are made to eliminate the risk that the intervention will have adverse effects on members of the target populations.
Effi cacy
Efficacy is a measure of the biologic impact of an intervention under controlled conditions. In the present context, an efficacy study would address the question of whether a specific cumulative dosage of micronutrients or a micronutrient-sparing procedure would result in a specific quantifiable effect, independent of confounding behavioral factors. Prior to any implementation of a program, one wants to know whether or not a measure "works" in a human biology sense. As such, efficacy studies are performed under carefully controlled, supervised, and regulated circumstances, assuring a quantitative delivery of micronutrients and minimizing sources of confounding. Bioavailability studies would proceed as a prelude to cohort studies in the field, and can be considered with this topic.
Research design
Before any other considerations, the construct validity of a study must be intact. By construct validity, we mean the theoretical (biologic) linkage between cause and effect. For instance, if we are going to use improvement in night blindness as the indicator of an efficacy study, we must be certain that a deficiency of the nutrient of interest can be responsible for the condition. For questions of vitamins A or E or zinc, dark adaptation performance would be a reasonable variable; for vita-min D, calcium, or vitamin B 12 , there is no known dependency of this ocular function on the nutrient.
The process of selecting variables must consider other issues. There are two classes of variables that can be used to assess impact in prospective, cohort trials of micronutrients: (1) static indices, and (2) functional indicators [37, 38] . On the static side, increased exposure to a nutrient can influence the total-body reserves or the body pool of a given nutrient. Measures that reflect the presence of a nutrient in a chemical or biochemical manner, based on the concentrations of an analyte (nutrient, metabolite) in a body fluid or tissue, are classified as "static" indices. Levels of nutrients or metabolites of interest in blood (plasma, serum, red cells, white cells, and platelets), and in urine, saliva, tears and cerumen constitute the static indices of body fluids. Biopsy materials for tissue analysis can range from non-invasively collected fingernails, toenails, hair, and buccal mucosal cells, to less innocuous biopsies of gingival and intestinal tissues, skeletal muscle, bone, and bone marrow.
On the functional side are the biochemical and physiologic reactions or whole-organism behaviors and performances. These include measures of functions that can only be a maximal individual capacity if one or a number of nutrients are in adequate supply. Dark adaptation is a classic example of a functional measure that depends on the intactness of nutriture for vitamin A, zinc, and vitamin E. Growth of children is another function dependent upon many macroand micronutrients. A long list of nutrient-dependent functions have been exploited for nutrition assessment [38] . Another dimension of functional assessment is to evaluate the state of homeostatic regulation of a nutrient's metabolism. If the body manifests excessive uptake or retention of a regulated nutrient, it suggests total-body deficiency; conversely, if there is reduced uptake or excessive excretion, this signifies adequacy or overload.
One of the limitations of functional assessment is person-to-person variation in the constitutional functions. Often it is necessary to administer a nutrient to determine whether the functional performance was nutrient-limited. Moreover, other conditions besides malnutrition can limit functional capacity. A functional test requiring visual acuity may be confounded in the elderly by underlying ocular diseases of aging.
Having the appropriate sample size and plan for analysis is essential in all types of multiple-micronutrient investigations. If the measurement of interest is variable, either multiple measurements in the same subject or a large number of subjects may be required to avoid a type II error in testing the null hypothesis of a treatment effect. The necessary sample size must be accomplished for the research results to permit valid conclusions. How the data will be expressed and how
Research needs in micronutrient defi ciencies S46 tests of hypotheses will be made are additional critical features of research design that can relegate a study to the status of useless or misleading. Interpretation of the study should also be favored by the design. When the issue is multiple micronutrients, one must provide opportunity, whenever possible, to assess interactions (synergistic, antagonistic) among micronutrients that are provided together in a trial.
Quality control
It is not enough simply to plan and execute collections and perform measurements. Quality control is a fundamental concern. A series of pitfalls are latent in the process of collecting data. How reliable is the test of effect? It can be unreliable because it provides the wrong answer, i.e., it is inaccurate or invalid. It can be unreliable because it provides variable answers from test to test, i.e., it is unstable or imprecise. Detecting inaccuracy and imprecision, and correcting them as best one can, are obligations of good research practice.
In some nutrient trials, namely in those in which an abnormal nutrition status is to be corrected by the intervention, the sensitivity (ability of a test to detect true abnormals) and specificity (ability of a test to detect true normals) of the measures are important. The entire gamut of quality-control issues comes into play with a new innovation in static indicators for field studies-when capillary blood samples are either preserved as liquid supernatant or applied to filter-paper cards and then dried to produce dried blood spots [39, 40] or dried serum spots [41] . This format is friendly to field investigation for the small amounts of blood involved, safety from viral transmission, and the lack of need for a cold-chain for storage and shipping.
Bioavailability indicators, absolute and relative
Among the questions to be asked at the efficacy stage in multi-micronutrient studies is whether-and to what extent-nutrient(s) are absorbed from a given preparation of supplement. The concept of "bioavailability" first emerged in the field of pharmacology, and was later adapted to the issues of uptake of nutrients and food constituents in the field of nutrition.
When a nutrient (or drug) is taken by mouth, it has three possible fates: (1) it can be taken up systemically into the body, (2) it can remain in the intestinal lumen or wall, only to be excreted intact in the feces, or (3) it can remain in the intestinal lumen or wall, outside of the inner systemic compartment, but be metabolized or destroyed in situ.
Strategies to determine uptake of a nutrient can follow one of two approaches in a bioavailability experiment [42] . One is to evaluate the amount or percentage of the administered dose that crosses the intestine and enters the systemic compartment; the other is to measure that which gets left behind, usually by collecting stool samples quantitatively and measuring the fecal nutrient content. A severe confounding factor for the latter approach, however, is any colonic degradation of the analyte(s) of interest.
The absorptive response can be evaluated in either absolute or relative terms. The absolute absorptive response takes into consideration the net quantitative amounts (grams, milligrams, moles) of nutrients taken up by the body. Relative absorption refers to the comparison between the appearance of nutrients in the bloodstream, tissues, or urine after a standard reference dose and that produced by the nutrient given in another form, such as in its native food matrix or incorporated into a meal. The latter approach has advantages insofar as it requires less prolonged and rigorous collections to determine effects and differential effects. However, it lacks the quantitative validity of determining what percentage of an administered dose actually becomes available to the host.
Ethics of effi cacy studies
The primary ethical issue for efficacy studies has been discussed above; it is that of safety. Suitable designs combine considerations of both healthful impact and potential adverse effects within the same context. The principle justification for a placebo (no-treatment) arm of a study is really related to safety concerns. It also improves the interpretation for definitive conclusions on the efficacy side. If, for any reason, a treatment arm without any potential to benefit the subjects is proscribed, a dose-response arrangement with a range of concentrations of the micronutrients can be assigned, or various combinations of micronutrients eliminating one nutrient from each treatment can allow for interpretation of efficacy (and safety) even without a no-treatment, placebo arm to the study.
With regard to collecting tissue or body fluid samples, minimum offensiveness or discomfort to the community or its participants is warranted. Urine and breast milk and even buccal mucosal swabs produce samples that are less objectionable than those of human blood. In an era of HIV transmission risk, these biologic samples are also safer for handlers and laboratory personnel [43] . Recent advances in microanalysis increasingly allow minute amounts of capillary blood from finger pricks to provide for assays that previously required milliliters of venous blood [43] .
Finally, a plan to handle situations of nutrient deficiency uncovered by the examination must exist, and be coherent and ethical. The efficacy study implies that undernourished individuals will be enrolled and observed for a period of time to see if a different rate of improvement is observed between placebo and treatment cohorts. The degree of severity of deficiency that would be unattended on discovery and left to be fol-S47 lowed over time must be defined and justified, and the length of time that any degree of abnormal nutrition would go without redress must be reasonable from an ethical point of view. A criterion of severe nutrition status that would require immediate response should be established, such that all children initially at that point (or reaching that status during the observation interval) would be offered therapeutic assistance from the study's resources. Moreover, after concluding a study, investigators should be prepared to assure that all persons remaining in an abnormal nutrition state will be provided access to appropriate therapies to return them to a state of adequate nutriture.
Effectiveness
Effectiveness is the measure of impact of a public health intervention when it is introduced into the regular health system, rather than with the excessive control of a research efficacy format. Does the desired biologic effect persist under all of the conditions of "real life"? It is unlikely that there will be a simultaneous comparison group. The "historical" control of the stable prevalence of deficiency prior to the intervention can be used as a reference, but it is a weaker standard than the placeboor dose-controlled formats of efficacy trials.
Because the context of effectiveness is in the "unguided" and "unsupervised" application of the intervention, one can document both process indicators as well as product (impact) indicators. Process indicators are the chain of actions and behaviors that are preconditions to the intervention's having the possibility of producing an effect. Such indicators would include the availability of the intervention's product, the distribution of products to stores, the number of purchases of the product, and the servings delivered within the home, etc. Also, if educational or promotional components exist, a process variable would be attendance of mothers at the communication points or events. These represent the explanatory variables that would allow interpretation of overall effectiveness measurement. If the process is not intact, the impact is unlikely to exist. However, even with the most favorable processes, the expected biologic impact may not occur. Hence, the fundamental indicators of effectiveness are those of the effect produced by the intervention. The same impact indicators as for efficacy are implied, as it is the biologic effect that represents the promise of improved nutrition status.
Ethics of effectiveness studies
The issues of placebo control are not part of effectiveness studies, because this type of inquiry covers only populations in which measures have been implemented on a routine basis, whether at a pilot scale or definitively. The ethical issues related to safety, conven-ience, and risk for making nutrition-impact measurements on the sentinel subjects in effectiveness studies are identical to those of efficacy studies. To the extent that receiving information on a subject's nutrition or physiologic status is considered to be a benefit of study, however, effectiveness studies might differ from those of efficacy. No formal control group is included, but a "similar" population, outside the coverage zone for the intervention, might be enrolled for comparison; the only benefit for such participants might be to gain information on personal nutrition status. For either the comparison group or the group covered by the program, the evaluation of nutrition status might reveal a deficiency state. Ethical considerations of whether just to inform the caretakers (and indicate that therapeutic care is required), or to be more proactive (and offer assessment and curative services from the investigation team itself) must be explored before the evaluative phase of an effectiveness study is taken to the field.
Effi ciency
The final concept is efficiency, which relates to the cost implementing and maintaining an efficacious and effective intervention program. It can be measured in terms of the brute resources necessary and the effects obtained. Such expressions may be the investment of "x" amount of funds to increase the mean height of the mean stature of the population by 2 cm, or to reduce the number of stunted individuals by half. The level of outlay can also be identified. For instance, the amount that a whole society would have to mobilize for an intervention in the collective public domain could be estimated, or that which a consuming family would have to spend to obtain the nutrition-promoting effects of a commercial product could be modeled into efficiency research.
Ethics of effi ciency studies
The ethical issues of this type of evaluation derive from those discussed for efficacy and efficiency, including using minimally invasive measurements and formulating a plan to respond to discovered cases of abnormal nutrition status. The full analysis of efficiency depends upon knowing effectiveness with the aforementioned ethical issues. If direct household interviews are required, however, one can enter into the sensitive area of individual incomes. Informants are often very reluctant to provide full disclosure in this area. Researchers must assure confidentiality of information to protect the interests of the subjects. A moral-ethical implication comes from the final efficiency evaluation. If it turns out that benefits come at a very high cost to the population benefited, one faces a serious value judgment as to whether the measure should be recommended for continued implementation.
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Research in communications and behavioral sciences
Aside from the biomedical and biologic variables implicit in the research areas discussed so far, issues of behavioral science and applied communication are also relevant. For instance, to understand processes of compliance (or non-compliance) at the stage of effectiveness evaluation, one can develop and administer research questionnaires or use informants in open-ended interviews or focus groups. Because this research is applied to specific modes of intervention, it cannot be conducted in the abstract, but rather with a specific micronutrient measure in mind. The objectives of the research are to document the current patterns of behavior in a population and to explore ways of changing behavior that are conducive to the participation in one or another micronutrient intervention with demonstrated biologic efficacy. So important are linguistics and culture that involvement of community members in social science research is virtually essential.
With respect to communication, research on finetuning and crafting messages to the public at the launch and during the maintenance of public health multimicronutrient interventions is an important part of the investigative agenda. Two primary issues to be investigated are how to gain access to the population and how to transmit a clear message. In theory, the instruction for a certain positive conduct could come through formal (schools, classes), informal (newspapers, television, internet), or non-formal (family, friends) modes of communication. Before deciding upon one or another medium, researchers should conduct formative research on how effectively the various modes can reach the population of interest. The more complex the behavior required, the more formality is needed to communicate the message clearly. The art of making any message clear and comprehensible, however, is the product of formative research in which social psychology, linguistics, and motivational aspects of the target population are understood. For the same reason that we use the term "hidden hunger" to denote micronutrient deficiencies, the "intangible" nature of micronutrients often makes it difficult to convey their importance to unaccustomed populations. Emphasis on the vehicles that need to be consumed and the benefits to be achieved may be more successful in achieving the desired behavior.
Ethical considerations in communications and behavior
Measurement of social science variables is inherently less invasive and less hazardous, because these variables do not involve human biologic materials; nonetheless, ethical issues arise. The basic issues of anonymity and confidentiality are fundamental. Autonomy is also important, and the participants must be voluntarily study participants. Often, however, one cannot be completely forthcoming as to the purposes of research, and measured deception (disguising true motives or surreptitiously observing) is often permissible at the behest of a sensitive human research committee.
To the extent that there are fewer risks and inconveniences in the measurements of these behaviors, there are also fewer benefits derived from their study. With nutrition status measures, one can often help the participants directly with remedial nutrition. The benefits, if any, that derive from behavioral research will apply only indirectly-if at all-to the subjects of study, and only in the long run with the implementation of programs.
With respect to communication, ethical considerations here have to do with the honesty and transparency of the use of final data. To the extent that communication techniques can alter behavior, it is important that they be mobilized in the genuine best interest of the health and nutrition of populations. More than the formality of ethical rules, it is the true morality and values of the investigators behind communication research and implementation that are important to protect the public from any damage in efforts to conquer micronutrient malnutrition.
Strategic priorities in research: mission
The previous section has covered the fundamental principles, caveats, and ethical considerations regarding the gamut of research studies that are part of the agenda for multi-micronutrient supplementation. The agenda, itself, however, does not arise from this listing of generic research principles without the application of a set of research priorities. If, indeed, the previous section addressed the tactics of the micronutrient research mission, this section deals with the strategy for that mission. From where do the priorities for specific research projects arise? The agenda for research on multi-micronutrient deficiencies must have two characteristics. First, it must derive from a convergence and consensus within the field of interested professionals; second, it must be appropriate and desirable to attract necessary resources.
Some insight into research priorities for the field can be gained from examining the outcomes of two meetings on this topic held over a 2-year period. The first was the workshop, Micronutrient Supplementation Throughout the Life Cycle, in Rio de Janeiro (November 1999) [44] . The range of specific research topics from annex 3 of that workshop's report [44] is reproduced in table 1. The other was the International Workshop on Multi-Micronutrient Deficiency Control in the Life Cycle, in Lima, Peru (May 30-June 1, 2001), and notably the product of its working group #4, whose agenda and matrix for discussion of research topics in Lima is presented in table 2.
Although different category headings are used to S49 denote the topics of each workshop, there is much similarity between the topics of the two workshops.
In the Rio meeting (table 1) , category 2 (functional indicators) and category 7 (diagnostic indicators), as well as the issues in category 1 (epidemiologic determinants of multi-micronutrient deficiencies) are all reflected under the five bullet-points of "assessment" in Lima (table 2) . Category 6 (cost considerations) from Rio and "cost-benefit" from Lima are also essentially identical. The issues of Rio's category 3 (efficacy of multimicronutrient supplementation in different age groups and physiologic states) are covered by the five headings of "efficacy/safety" from Lima. In Lima, the group went much farther, however, and this is where the departures from the Brazil process begin to emerge in the later Peruvian considerations. Notable is the absence of safety as a specific component-or even any explicit written mention of the word-in the Rio de Janeiro meeting, at which the IRIS study was launched. Two years later, when preliminary data from IRIS were presented in Lima, it was not hard to understand why safety was both mentioned and ranked as the primary issue for the field. Preliminary indications of a potential adverse effect of iron supplementation emerged from at least two of the field sites.
The social sciences issues in multi-micronutrients are one of the major disconnections between the two workshops. In Rio, category 5 was "communication," with no further detail or adorning information (table 1). One must, then, read the text of the report [44] for a sense of the context given to communication research at that workshop. The meeting in Rio de Janeiro identified a series of audiences for the communication messages to be targeted to. The primary audience comprised those who were deficient themselves [45] .
Research needs in micronutrient defi ciencies S50 (consumers), or their caretakers if they were minors. The secondary audience were those who would influence the primary audience, including community opinion leaders, health professionals, family members, and peers. Finally, the tertiary audience included policy and decision makers, donors, academics, professional societies, and the media. Inputs of the latter are needed to make any program a success.
In the Lima workshop (table 2) , communication fell as a bullet-point under "behavioral issues," along with cultural perception, compliance, and dosing schedule. Perhaps what is common to the social-science component is a need for a two-stage research consideration. The first tier would be a situation analysis to identify the knowledge, attitudes, practices, and perceptions surrounding the behavioral issues. The second would be the applied research-based around the formerthat shapes the most effective messages to communicate and advocate for the program to each of the three levels of audience.
Also interesting is the positioning in the Rio table  (table 1) of communication, i.e., between the categories of efficacy and effectiveness (above it) and that of cost-benefit or what can now be called efficiency (below it). This calls upon us to accept the notion that successful communication is, indeed, the link that makes an effective program appropriate for its cost. Logically, however, this is not a reasonable hypothesis. A more logical rationale is that communication be the link between the biologic efficacy of a multi-micronutrient intervention and its continued effectiveness of impact at the public health level.
The final category from the Rio meeting makes an explicit statement about the formulation of the intervention, i.e., as a non-drug supplement. The Rio meeting gave birth to the concept of the "foodlet" (i.e., food plus tablet), which was the basis of the IRIS protocol. Some workshop participants were disappointed with the actual foodlet. Most saw it more as a medicinal tablet than as a food item. If the philosophic and practical goals of such interventions are that the supplements function more as food than as medicine, then more food science and food technology research is necessary. Because some vitamins, such as riboflavin, vitamin C, and folic acid, are perishable, the use of the supplement with other (high temperature) foods and beverages is now seen as critical and merits further study. In the Lima meeting, issues surrounding formulation are described under the heading "delivery issues," which embraces a series of characteristics of a multi-micronutrient supplement. The Lima meeting suggested more latitude and flexibility among the vehicles, considering the medicinal extremes (powders, tablets, liquids), as well as food vehicles (fat-based spreads). Research on the acceptability of any potential product and the bioavailability of its nutrients is necessary. Regarding bioavailability, a working group in Lima identified two potential interactions: nutrient-nutrient and food-nutrient.
The issue of forced creation and ranking of priorities was not a component of the early exercise in Rio de Janeiro, but it was a specific mandate of working group #4 at the Lima meeting. We now know that we cannot really talk about research that we would like to see conducted in any academic or theoretical wish list. Rather, we are forced to project choices among various options. The impetus for prioritizing research clearly gathered force over the 2-year interim between the Rio and Lima workshops. One possible explanation is the worldwide economic recession that occurred between 1999 and 2001. The attendees in 2001 were undoubtedly conscious of budgetary constraints in their own lives and work. The factor of actually having the IRIS I study to examine, however, may have been another stimulus toward a mandate to set priorities. Please see pages S58-S61 in this supplement for a working group report by the rapporteurs of breakout section #4 on research [45] for a narrative on how the participants reacted to the matrix in our table 2 and established priorities deemed more or less urgent for immediate action. The presentation of the preliminary findings of IRIS I in Lima provided actual experience to analyze, and in analyzing it, we were guided to weaknesses, deficiencies, and unexpected consequences, and began to build a priority hierarchy suited to address the gaps.
Capacity building for research
The inherent distribution of interests in the issues of micronutrient deficiencies and their partisans has implications for an additional issue: that of capacity building. Inherently, micronutrient deficiencies are more commonly seen in low-income populations in developing countries. This is the region where the benefits are to be realized and where human research must be performed. Public health officials of affected areas should be those responsible for the collective good, and be agents to mobilize resources to improve the micronutrient situation for the populace. They would call for-and call on-the applied research and technology needed to resolve the problems. Various industries can contribute by producing isolated nutrients, preparing supplementation vehicles or food fortificants, and/or processing foods and foodlets. Finally, academic institutions for research (universities, medical schools, institutes) have roles in the diagnostic, surveillance, monitoring, pharmaceutical, and food technology studies.
The poverty and deprivation that would make a region vulnerable to micronutrient deficiency would Gross and Solomons S51 also limit the professional and infrastructural development of local health authorities, private industries, and academic institutions. For these reasons, the somewhat 'privileged' consortium of entities involved in the Rio and Lima workshops has a role internationally in framing the 'generic' approaches to solving micronutrient deficiency. It also has the opportunity-and perhaps the responsibility-to advocate for capacity building at the local level to incorporate efforts that will leave the public health, commercial industry, and academic sectors strengthened as a consequence of participating in creating and evaluating interventions against micronutrient malnutrition.
Modern information technology can provide a platform, as well. Websites can contain a plethora of information, including the fundamentals and principles of action, the experiences and lessons learned from activities, and even online "chat rooms" for discussion and information sharing. Websites are generally low-cost, but it is crucial to make sure the information is available in several different languages. More costly, but possibly equally cost-effective, would be to organize local workshops in vulnerable areas to identify and mobilize, then orient and mentor, the appropriate individuals and entities in the health, academic, and business communities. The academic institutions and industries represented in Lima, and the histories of individual workshop attendees, constitute a rich tradition of training professionals competent in micronutrient investigation.
Agencies such as the United Nations University, the International Atomic Energy Agency, UNICEF, etc., can provide mechanisms within their assistance policies to assure that the capacity for designing and conducting high-quality and useful research is imparted to professionals in the countries in which such investigation is most relevant.
Future research directions
Clearly, safety issues must be a top priority of researchers, as well as donors. Faith in the notion so strongly expressed at the workshop in Rio, that "one RDA of a nutrient must be safe," must be questioned. Qualitative differences between one RDA in foods and the same amount in chemical form can exist. This can be mediated by nutrient-nutrient interactions or effects in populations adapted to chronically low intakes. Unless safety is considered, the appropriate indicators may not be measured and adverse effects may be missed. Ethical issues must be carefully weight in any future studies, particularly those involving children.
For studies of bioavailability, radioisotopes are convenient and precise, but they may also represent exposure to ionizing radiation, as well as an environmental hazard. The use of stable (non-radioactive) isotope technology in field studies for both vitamins [46, 47] and minerals [48, 49] has emerged and been perfected, allowing for studies of low invasiveness and no biohazards for both bioavailability and nutrition status monitoring.
Finally, we anticipate a paradigm shift with regard to nutrition research in developing countries [50]a shift away from interventions only to protect against micronutrient deficiency and toward those that also include longer-term health promotion. Studies suggest that those who took selenium supplements had lower rates of some cancers [51] and higher intakes of antioxidants preventing cataracts or macular degeneration [52, 53] . To become prudent public health policy, any and all modifications of multi-micronutrient dosing must continue to be rigorously assessed to assure that they are safe, efficacious, effective, and efficient (costeffective), and have the appropriate biologic availability of the nutrients offered.
